- The outcome of patients with follicular lymphoma in the rituximab era treated with autologous stem cell transplant according to the high-dose regimen received. A retrospective study of the EBMT Lymphoma Working Party.Publication without faculty affiliation
- Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT)2010 | First Faculty of Medicine
- Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma2012 | First Faculty of Medicine
- Retrospective Analysis of the Results of High-dose Chemotherapy with the Support of Autologous Blood Stem Cells in Patients with Multiple Myeloma. The Experience of a Single Centre2010 | First Faculty of Medicine
- Comparative PCR as a Tool for Monitoring in Patients Undergoing HDT and ASCT.2000 | Publication without faculty affiliation
- Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT2021 | First Faculty of Medicine
- Advances in multiple myeloma therapy during two past decades2014 | First Faculty of Medicine
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Separation of hematopoietic progenitor cells from peripheral blood (PBPC) in patients with hematooncologic malignancies.1999 | Faculty of Physical Education and Sport
- Alpha administration as post-transplant immunotherapy in malignant lymphomas.1999 | Faculty of Physical Education and Sport
- Interleukin-2 Immunotherapy early after autologous stem cell transplantation for malignantnlmyphomas - a dose escalation study.1999 | Faculty of Physical Education and Sport
- Prognostic factors and markers of activity in multiple myeloma2000 | First Faculty of Medicine
- Comparative Multiplex Polymerase Chain Reaction (PCR) as a Helpful Tool for Monitoring in Patients with LymphomasUndergoing High-dose Therapy (HDT) with Autologous Stem Cell Transplantation (ASCT).2000 | Faculty of Physical Education and Sport
- Comparative Multiplex Polymerase Chain Reaction (PCR) as a Helpful Tool for Monitoring in Patients with LymphomasUndergoing High-dose Therapy (HDT) with Autologous Stem Cell Transplantation (ASCT).2000 | Publication without faculty affiliation
- Treatment of high-risk mediastinal diffuse large B-cell lymphoma (DLBCL) with megachop and autologous transplant (ASCT)Publication without faculty affiliation
- Treatment of high-risk madiastinal diffuse large B-cell lymphoma(DLBCL) with MegaCHOP and autologus transplant(ASCT)Publication without faculty affiliation
- Treatment of relapsed and refractory Hodgkin lymphoma2010 | Third Faculty of Medicine
- Prognostic factors and markers of activity in multiple myeloma: Results of the Cooperative Group for Diagnostic and Treatment of Multiple Myeloma2000 | First Faculty of Medicine
- Impaired intestinal resorption caused by cytostatic treatment - Effect of parenteral glutamine and the preparatory regime2002 | First Faculty of Medicine, Third Faculty of Medicine
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine
- High pre-transplant Mucosal Associated Invariant T Cell (MAIT) count predicts favorable course of myeloid aplasia2023 | Third Faculty of Medicine
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- ENDOTHELIAL CELLS (EC) AND ENDOTHELIAL PRECURSOR CELLS (EPC) KINETICS IN HAEMATOLOGICAL PATIENTS UNDERGOING CHEMOTHERAPY OR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)Publication without faculty affiliation
- Treatment of high-risk diffuse large B-cell lymphoma (DLBCL) with rituximab, high-dose CHOP, ESHAP and autologous transplant (ASCT)Publication without faculty affiliation
- Immuno chemotherapy (anti CD20 and fludarabin/cyclophosphamide) and high dose chemotherapy with ASCT increases molecular remission rate but cannot pretend relapsesPublication without faculty affiliation
- Immuno chemotherapy (Anti CD20 and Fludarabin/Cyclophosphamide) and high dose chemotherapy with ASCT increases molecular remission rate but cannot prevent relapsesPublication without faculty affiliation
- Favorable Outcome of High-Risk Mediastinal Diffuse Large B-Cell Lymphoma (DLBCL) after Dose-Intensive Chemotherapy, Rituximab and Autologous Transplant (ASCT)Publication without faculty affiliation
- Favorable outcome of high-risk mediastnal diffuse large B-cell lymphoma(DLBCL) after dose-intensive chemoterapy, rituximab and autologous transplant(ASCT)Publication without faculty affiliation
- Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience +12008 | Faculty of Medicine in Hradec Králové